Gut microbiota modulate CD8⁺ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX

References

• Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. doi:10.1371/journal.pbio.1002533.
   PubMed Web of Science ®Google Scholar
• Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17(5):271–30. doi:10.1038/nrc.2017.13.
   PubMed Web of Science ®Google Scholar
• Dzutsev A, Goldszmid R, Viaud S, Zitvogel L, Trinchieri G. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur J Immunol. 2015;45(1):17–31. doi:10.1002/eji.201444972.
   PubMed Web of Science ®Google Scholar
• Maeda Y, Kurakawa T, Umemoto E, Motooka D, Ito Y, Gotoh K, Hirota K, Matsushita M, Furuta Y, Narazaki M. et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis & Rheumatology (Hoboken, N J). 2016;68(11):2646–2661. doi:10.1002/art.39783.
   PubMed Web of Science ®Google Scholar
• Matsushita M, Fujita K, Hayashi T, Kayama H, Motooka D, Hase H, Jingushi K, Yamamichi G, Yumiba S, Tomiyama E. et al. Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling. Cancer Res. 2021;81(15):4014–4026. doi:10.1158/0008-5472.CAN-20-4090.
   PubMed Web of Science ®Google Scholar
• Ishikawa D, Sasaki T, Osada T, Kuwahara-Arai K, Haga K, Shibuya T, Hiramatsu K, Watanabe S. Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for Ulcerative Colitis. Inflamm Bowel Dis. 2017;23(1):116–125. doi:10.1097/MIB.0000000000000975.
   PubMed Web of Science ®Google Scholar
• Woelk C, Snyder A. Modulating gut microbiota to treat cancer. Sci (New York, NY). 2021;371(6529):573–574. doi:10.1126/science.abg2904.
   Google Scholar
• Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Watanabe H, Masuda K, Nishimoto Y, Kubo M. et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25(6):968–976. doi:10.1038/s41591-019-0458-7.
   PubMed Web of Science ®Google Scholar
• Schulz M, Atay C, Heringer J, Romrig FK, Schwitalla S, Aydin B, Ziegler PK, Varga J, Reindl W, Pommerenke C. et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature. 2014;514(7523):508–12. doi:10.1038/nature13398.
   PubMed Web of Science ®Google Scholar
• Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre M-L. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Sci (New York, NY). 2015;350(6264):1084–9. doi:10.1126/science.aac4255.
   Google Scholar
• Dong X, Pan P, Zheng D, Bao P, Zeng X, Zhang X-Z. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer. Sci Adv. 2020;6(20):eaba1590. doi:10.1126/sciadv.aba1590.
   PubMed Web of Science ®Google Scholar
• Chen T, Li Q, Wu J, Wu Y, Peng W, Li H, Wang J, Tang X, Peng Y, Fu X. et al. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism. Cancer Immunol Immunother. 2018;67(10):1635–1646. doi:10.1007/s00262-018-2233-x.
   PubMed Web of Science ®Google Scholar
• Binnewies M, Roberts E, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541–550. doi:10.1038/s41591-018-0014-x.
   PubMed Web of Science ®Google Scholar
• Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446–50. doi:10.1038/nature12721.
   PubMed Web of Science ®Google Scholar
• Yahoo N, Dudek M, Knolle P, Heikenwälder M. Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation. Journal Of Hepatology. 2023;79(2):538–551. doi:10.1016/j.jhep.2023.02.033.
   PubMed Web of Science ®Google Scholar
• Hu C, Xu B, Wang X, Wan W-H, Lu J, Kong D, Jin Y, You W, Sun H, Mu X. et al. Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC. Hepatol. 2023;77(1):48–64. doi:10.1002/hep.32449.
   PubMed Web of Science ®Google Scholar
• Balmer M, Ma E, Thompson A, Epple R, Unterstab G, Lötscher J, Dehio P, Schürch CM, Warncke JD, Perrin G. et al. Memory CD8+ T cells balance pro- and anti-inflammatory activity by reprogramming cellular acetate handling at sites of infection. Cell Metab. 2020;32(3):457–467.e5. doi:10.1016/j.cmet.2020.07.004.
   PubMed Web of Science ®Google Scholar
• Tyagi A, Yu M, Darby T, Vaccaro C, Li J-Y, Owens JA, Hsu E, Adams J, Weitzmann MN, Jones RM. et al. The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression. Immunity. 2018;49(6):1116–1131.e7. doi:10.1016/j.immuni.2018.10.013.
   PubMed Web of Science ®Google Scholar
• Tan J, McKenzie C, Mariño E, Macia L, Mackay CR. Metabolite-sensing G protein–coupled receptors—facilitators of diet-related immune regulation. Annu Rev Immunol. 2017;35(1):371–402. doi:10.1146/annurev-immunol-051116-052235.
   PubMedGoogle Scholar
• Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad P, Manicassamy S, Munn D. et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40(1):128–39. doi:10.1016/j.immuni.2013.12.007.
   PubMed Web of Science ®Google Scholar
• Lu H, Xu X, Fu D, Gu Y, Fan R, Yi H, He X, Wang C, Ouyang B, Zhao P. et al. Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-κB axis. Cell Host & Microbe. 2022;30(8):1139–1150.e7. doi:10.1016/j.chom.2022.07.003.
   PubMed Web of Science ®Google Scholar
• Priyadarshini M, Kotlo K, Dudeja P, Layden BT. Role of short chain fatty acid receptors in intestinal physiology and pathophysiology. Compr Physiol. 2018;8(3):1091–1115. doi:10.1002/cphy.c170050.
   PubMed Web of Science ®Google Scholar
• Docampo M, da Silva M, Lazrak A, Nichols KB, Lieberman SR, Slingerland AE, Armijo GK, Shono Y, Nguyen C, Monette S. et al. Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease. Blood. 2022;139(15):2392–2405. doi:10.1182/blood.2021010719.
   PubMed Web of Science ®Google Scholar
• Miao Z, Sun J, Adkins-Threats M, Pang M-J, Zhao J-H, Wang X, Tang K-W, Wang Z-N, Mills JC. DDIT4 licenses only healthy cells to proliferate during injury-induced metaplasia. Gastroenterology. 2021;160(1):260–271.e10. doi:10.1053/j.gastro.2020.09.016.
   PubMed Web of Science ®Google Scholar
• Ji L, Qian W, Gui L, Ji Z, Yin P, Lin GN, Wang Y, Ma B, Gao W-Q. Blockade of β-Catenin–Induced CCL28 suppresses gastric cancer progression via inhibition of treg cell infiltration. Cancer Res. 2020;80(10):2004–2016. doi:10.1158/0008-5472.CAN-19-3074.
   PubMed Web of Science ®Google Scholar
• Hayakawa Y, Jin G, Wang H, Chen X, Westphalen CB, Asfaha S, Renz BW, Ariyama H, Dubeykovskaya ZA, Takemoto Y. et al. CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis. Gut. 2015;64(4):544–53. doi:10.1136/gutjnl-2014-307190.
   PubMed Web of Science ®Google Scholar
• Dmitrieva-Posocco O, Wong A, Lundgren P, Golos AM, Descamps HC, Dohnalová L, Cramer Z, Tian Y, Yueh B, Eskiocak O. et al. β-Hydroxybutyrate suppresses colorectal cancer. Nature. 2022;605(7908):160–165. doi:10.1038/s41586-022-04649-6.
   PubMed Web of Science ®Google Scholar
• Lynch S, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369–2379. doi:10.1056/NEJMra1600266.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. doi:10.1038/s41579-020-0433-9.
   PubMed Web of Science ®Google Scholar
• Perler B, Friedman E, Wu G. The role of the gut microbiota in the relationship between diet and human health. Annu Rev Physiol. 2023;85:449–468. doi:10.1146/annurev-physiol-031522-092054.
   PubMed Web of Science ®Google Scholar
• Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018;67(9):1716–1725. doi:10.1136/gutjnl-2018-316723.
   PubMed Web of Science ®Google Scholar
• Wong S, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastro Hepat. 2019;16:690–704.
   PubMed Web of Science ®Google Scholar
• Lu J, Zhang L, Zhai Q, Zhao J, Zhang H, Lee Y-K, Lu W, Li M, Chen W. Chinese gut microbiota and its associations with staple food type, ethnicity, and urbanization. npj Biofilm Microbio. 2021;7(1):71. doi:10.1038/s41522-021-00245-0.
   PubMed Web of Science ®Google Scholar
• Zhang J, Guo Z, Xue Z, Sun Z, Zhang M, Wang L, Wang G, Wang F, Xu J, Cao H. et al. A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities. ISME J. 2015;9(9):1979–90. doi:10.1038/ismej.2015.11.
   PubMed Web of Science ®Google Scholar
• Cai S, Fan Y, Zhang, B. et al. Appendectomy is associated with alteration of human gut bacterial and fungal communities. Front Microbiol. 2021;12:724980. doi:10.3389/fmicb.2021.724980.
   PubMed Web of Science ®Google Scholar
• Lee J, d’Aigle J, Atadja L, Quaicoe V, Honarpisheh P, Ganesh BP, Hassan A, Graf J, Petrosino J, Putluri N. et al. Gut microbiota–derived short-chain fatty acids promote poststroke recovery in aged mice. Circ Res. 2020;127(4):453–465. doi:10.1161/CIRCRESAHA.119.316448.
   PubMed Web of Science ®Google Scholar
• Louis P, Flint H. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29–41. doi:10.1111/1462-2920.13589.
   PubMed Web of Science ®Google Scholar
• Guo M, Li Z. Polysaccharides isolated from Nostoc commune Vaucher inhibit colitis-associated colon tumorigenesis in mice and modulate gut microbiota. Food Funct. 2019;10(10):6873–6881. doi:10.1039/C9FO00296K.
   PubMed Web of Science ®Google Scholar
• Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23(1):107–113. doi:10.1038/nm.4236.
   PubMed Web of Science ®Google Scholar
• Wang L, Tang L, Feng Y, Zhao S, Han M, Zhang C, Yuan G, Zhu J, Cao S, Wu Q. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice. Gut. 2020;69(11):1988–1997. doi:10.1136/gutjnl-2019-320105.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Sci (New York, NY). 2018;359(6380):1151–1156. doi:10.1126/science.aao5774.
   Google Scholar
• Zheng D, Li R, An J, Xie T-Q, Han Z-Y, Xu R, Fang Y, Zhang X-Z. Prebiotics-Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer. Adv Mater. 2020;32(45):e2004529. doi:10.1002/adma.202004529.
   PubMed Web of Science ®Google Scholar
• Morrison D, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189–200. doi:10.1080/19490976.2015.1134082.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen F, Wu W, Sun M, Bilotta AJ, Yao S, Xiao Y, Huang X, Eaves-Pyles TD, Golovko G. et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunol. 2018;11(3):752–762. doi:10.1038/mi.2017.118.
   PubMed Web of Science ®Google Scholar
• Shao X, Sun S, Zhou Y, Wang H, Yu Y, Hu T, Yao Y, Zhou C. Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis. Cancer Lett. 2021;523:170–181. doi:10.1016/j.canlet.2021.10.002.
   PubMed Web of Science ®Google Scholar
• Donohoe DR, Holley D, Collins LB, Montgomery SA, Whitmore AC, Hillhouse A, Curry KP, Renner SW, Greenwalt A, Ryan EP. et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 2014;4(12):1387–97. doi:10.1158/2159-8290.CD-14-0501.
   PubMed Web of Science ®Google Scholar
• Singh V, Yeoh B, Chassaing B, Xiao X, Saha P, Aguilera Olvera R, Lapek JD, Zhang L, Wang W-B, Hao S. et al. Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell. 2018;175(3):679–694.e22. doi:10.1016/j.cell.2018.09.004.
   PubMed Web of Science ®Google Scholar
• Chen D, Jin D, Huang S, Wu J, Xu M, Liu T, Dong W, Liu X, Wang S, Zhong W. et al. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 2020;469:456–467. doi:10.1016/j.canlet.2019.11.019.
   PubMed Web of Science ®Google Scholar
• Bachem A, Makhlouf C, Binger K, de Souza DP, Tull D, Hochheiser K, Whitney PG, Fernandez-Ruiz D, Dähling S, Kastenmüller W. et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T cells. Immunity. 2019;51(2):285–297.e5. doi:10.1016/j.immuni.2019.06.002.
   PubMed Web of Science ®Google Scholar
• Zolbetuximab Improves Survival in Gastric Cancer. Cancer discovery. Zolbetuximab improves survival in gastric cancer. Cancer Discov. 2023;13(3):520–521. doi:10.1158/2159-8290.CD-NB2023-0006.
   Web of Science ®Google Scholar
• Sahin U, Türeci Ö, Manikhas G, Lordick F, Rusyn A, Vynnychenko I, Dudov A, Bazin I, Bondarenko I, Melichar B. et al. FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma. Ann Oncol. 2021;32(5):609–619. doi:10.1016/j.annonc.2021.02.005.
   PubMed Web of Science ®Google Scholar
• Petrillo A, Smyth E, van Laarhoven H. Emerging targets in gastroesophageal adenocarcinoma: what the future looks like. Ther Adv Med Oncol. 2023;15:17588359231173177. doi:10.1177/17588359231173177.
   Web of Science ®Google Scholar